Overweight: Clinical Trials

58 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 unknown. 58 Phase 3, 17 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 358Unknown 58
Phase 217Unknown 17

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 58 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Triticum Aestivum on Appetite, Ghrelin, Leptin, Adiponectin Hormonal Axis in Patients With Obesity
Triticum Aestivum, Placebo (calcined magnesia) - Obesity, Leptin Deficiency
Phase 3UnknownCoordinación de Investigación en Salud, Mexico382024-01-032024-07-11
A Study of IBI362 9 mg in Chinese Adults With Obesity
IBI362, Placebo - Obesity
Phase 3UnknownInnovent Biologics (Suzhou) Co. Ltd.4622023-12-272024-08-27
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
Liraglutide + Metformin, Metformin - Polycystic Ovary Syndrome, Obesity
Phase 3UnknownMỹ Đức Hospital1882023-11-012023-10-23
Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy
peri-wound Transversus Abdominis Plane Block, Local wound infiltration - Morbid Obesity, Laparoscopic Sleeve Gastrectomy
Phase 2 / Phase 3UnknownKhon Kaen University982023-04-292024-05-01
Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
Xian-Hua-Cha - Hyperlipidemias, Obesity
Phase 3UnknownChang Gung Memorial Hospital1002022-12-132024-10-08
Effect of Triticum Aestivum vs Placebo on Metabolic Profile Components and Insulin Sensitivity in Patients With Obesity
Triticum Aestivum, Placebo (calcined magnesia) - Obesity, Drug Effect
Phase 3UnknownCoordinación de Investigación en Salud, Mexico362022-07-142024-07-15
Dose of Magnesium Sulfate Infusion in Obese
Lactate ringer group, Magnesium sulfate dose through real weight group, Magnesium sulfate dose through corrected ideal weight group - Obese, Analgesia
Phase 3UnknownUniversity of Sao Paulo General Hospital752022-04-012023-10-31
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
Follow-up study of the treated cohort, Follow-up study of the untreated cohort - Prader-Willi Syndrome
Phase 3UnknownUniversity Hospital, Toulouse802021-09-072024-04-30
Naldebain for Pain Control After Bariatric Surgery
Dinalbuphine sebacate, Placebo solution - Pain, Postoperative, Pain, Chronic
Phase 2 / Phase 3UnknownE-DA Hospital602021-06-242021-12-28
Ketamine Infusion vs Dexmedetomidine Infusion in Obese Patients Undergoing Bariatric Surgery
Ketamine, Dexmedetomidine, Normal Saline 0.9% - Morbid Obesity, Surgery
Phase 3UnknownAin Shams University902021-04-202021-07-28
Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
Liraglutide, placebo - Obesity
Phase 3UnknownXiangya Hospital of Central South University3002020-05-242020-08-25
Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
Liraglutide, placebo - Obesity
Phase 3UnknownXiangya Hospital of Central South University3002020-05-092020-07-27
Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial
Botulinum toxin type A, Weight Management Program - Obesity, Weight Loss
Phase 2 / Phase 3UnknownTan Tock Seng Hospital182020-01-012020-02-18
Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
Benaglutide, Liraglutide - Obesity
Phase 3UnknownXiangya Hospital of Central South University602019-12-012021-04-09
Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-II
Tadalafil 20 MG - Obesity and Erectile Dysfuntion
Phase 3UnknownCentro Universitario de Ciencias de la Salud, Mexico802019-05-012019-04-05
ReShape Vest™ for the Treatment of Obesity (Europe)
Laparoscopic Gastric Vest (LGV) - Obesity, Weight Loss
Phase 2 / Phase 3UnknownReShape Lifesciences652019-03-252020-02-24
The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters.
Glycine - Metabolic Syndrome, Dyslipidemias
Phase 2 / Phase 3UnknownProf. Tony hayek MD502019-03-012019-02-21
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Liraglutide, Exenatide, Exenatide Microspheres for Injection - Obesity
Phase 3UnknownXiangya Hospital of Central South University1502018-09-012021-04-09
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
Recombinant Human Growth Hormone (rhGH) Injection - Prader-Willi Syndrome
Phase 3UnknownChangchun GeneScience Pharmaceutical Co., Ltd.302018-04-142018-06-12
Intranasal Glucagon and Energy Balance
Glucagon, Placebo - Obesity
Phase 2 / Phase 3UnknownUniversity Health Network, Toronto202017-06-062018-08-31

Showing 20 of 58. Sign in to see all of them.

Narrower conditions

Obesity (47)  ·  Obesity, Morbid (10)  ·  Diabetes Mellitus, Type 2 (5)  ·  Insulin Resistance (5)  ·  Weight Loss (5)  ·  Diabetes Mellitus (3)  ·  Dyslipidemias (3)  ·  Metabolic Syndrome (3)  ·  Body Weight (2)  ·  Breast Neoplasms (2)  ·  Hypertension (2)  ·  Inflammation (2)  ·  Prader-Willi Syndrome (2)  ·  Respiratory Aspiration (2)

Broader conditions

Nutrition Disorders (58)  ·  Nutritional and Metabolic Diseases (58)  ·  Overnutrition (58)  ·  Pathological Conditions, Signs and Symptoms (56)  ·  Signs and Symptoms (56)  ·  Body Weight (54)  ·  Metabolic Diseases (17)  ·  Glucose Metabolism Disorders (15)  ·  Endocrine System Diseases (11)  ·  Obesity (10)  ·  Hyperinsulinism (8)  ·  Diabetes Mellitus (7)  ·  Pathologic Processes (7)  ·  Body Weight Changes (5)

Interventions

Liraglutide (6)  ·  Metformin (3)  ·  Exenatide (2)  ·  Flour (2)  ·  Ketamine (2)  ·  Sugammadex (2)  ·  5,10-dihydro-5-methylphenazine (1)  ·  Alprostadil (1)  ·  Botulinum Toxins, Type A (1)  ·  Brachytherapy (1)  ·  Butyrates (1)  ·  Capsaicin (1)  ·  Carboplatin (1)  ·  Combined Modality Therapy (1)  ·  Counseling (1)

Sponsors

Xiangya Hospital of Central South University (4)  ·  Chinese University of Hong Kong (2)  ·  Coordinación de Investigación en Salud, Mexico (2)  ·  University of Padova (2)  ·  University of Patras (2)  ·  Advanced Specialty Care (1)  ·  Ain Shams University (1)  ·  Biopolis S.L. (1)  ·  Bridgeport Hospital (1)  ·  Brigham and Women's Hospital (1)  ·  Centro Universitario de Ciencias de la Salud, Mexico (1)  ·  Chang Gung Memorial Hospital (1)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (1)  ·  Charite University, Berlin, Germany (1)  ·  Children's Hospital of Eastern Ontario (1)

Countries

China (9)  ·  United States (8)  ·  Mexico (5)  ·  Brazil (3)  ·  Israel (3)  ·  Italy (3)  ·  South Korea (3)  ·  Spain (3)  ·  Australia (2)  ·  Canada (2)  ·  Greece (2)  ·  Taiwan (2)  ·  Belgium (1)  ·  Egypt (1)  ·  France (1)

Top investigators

Jing Wu (3)  ·  Ahmed N El-Shaer, PhD (1)  ·  Almantas Maleckas (1)  ·  Antonio Peralta, MD (1)  ·  Asnat Walfisch, MD (1)  ·  Athena Siampalioti, M.D. (1)  ·  Athina Siampalioth, MD (1)  ·  Ayman M Arafat, Dr.med. (1)  ·  Bahaa El-Din E Ali, PhD (1)  ·  Belal N Khalil, M.Sc (1)  ·  Bruna Pontin, MD (1)  ·  Bruno Geloneze, MD, PhD (1)  ·  Carl-Erik Flodmark, MD, PhD (1)  ·  Chen-Fuh Lam, MD, PhD (1)  ·  Clude Marcus, Prof, MD (1)

Results publications

PMID 11527911, PMID 14688154, PMID 17980364, PMID 18068166, PMID 18364705, PMID 19056992, PMID 19640956, PMID 19841045, PMID 20124139, PMID 22117618, PMID 22767467, PMID 23966238, PMID 24151290, PMID 24362411, PMID 24491362, PMID 24581574, PMID 24789668, PMID 25682903, PMID 25710812, PMID 26401593, PMID 2670645, PMID 27071497, PMID 27459230, PMID 28065734, PMID 28479118, PMID 28681988, PMID 28760517, PMID 28961722, PMID 29063494, PMID 29703793, PMID 30033227, PMID 30660196, PMID 30995174, PMID 31031702, PMID 31229399, PMID 31238940, PMID 31733195, PMID 31978372, PMID 32442310, PMID 33079376, PMID 33552465, PMID 34583840, PMID 36996264, PMID 37005580, PMID 40144953, PMID 42251595

NIH funding

U10CA027469 (1), U10CA180868 (1)